LIXTE BIOTECHNOLOGY HOLDINGS (LIXT)

US5393193017 - Common Stock

2.4004  +0 (+0.02%)

After market: 2.4 0 (-0.02%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

MRQ
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
ASSETS
Current Assets
Cash
1.64M4.20M5.35M4.82M5.07M
Marketable Securities
N/AN/AN/AN/AN/A
Receivables
N/AN/AN/AN/A0.00
Other Current Assets
51.34K105.14K210.00K270.00K160.00K
Total Current Assets
1.69M4.31M5.56M5.09M5.23M
 
Non-Current Assets
Other Non-Current Assets
6.93KN/AN/AN/AN/A
Total Non-Current Assets
6.93K0.000.000.000.00
 
TOTAL ASSETS
1.70M4.31M5.56M5.09M5.23M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
N/AN/AN/A0.0010.00K
Accounts Payable
72.86K156.76K230.00K230.00K190.00K
Other Current Liabilities
256.10K157.10K170.00K80.00K20.00K
Total Current Liabilities
328.96K313.86K390.00K300.00K220.00K
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Total Non-Current Liabilities
0.000.000.000.000.00
 
TOTAL LIABILITIES
328.96K313.86K390.00K300.00K220.00K
 
SHAREHOLDERS' EQUITY
Retained Earnings
-51.45M-48.48M-43.39M-37.08M-30.35M
Additional Paid In Capital
49.32M48.98M45.06M38.37M31.86M
Common Shares
3.50M3.50M3.50M3.50M3.50M
Shares Outstanding
2.25M2.25M1.66M1.37M1.24M
Tangible Book Value per Share
-0.950.221.010.941.22
Total Shareholders' Equity
1.37M3.99M5.17M4.79M5.01M
 
TOTAL LIABILITIES AND EQUITY
1.70M4.31M5.56M5.09M5.23M
 
Statistics
Current Ratio
5.1313.7314.2616.9723.77
Return On Assets (ROA)
-235.90%-118.07%-113.49%-132.22%-62.33%
Return On Equity (ROE)
-292.66%-127.34%-122.05%-140.50%-65.07%

All data in USD , ROIC based on taxRate of 0.21

Charts